In this video we spoke with Courtney Fletcher, the clinical trial coordinator for Medlab clinical. Courtney gives a background on this clinical trial and explains how Australian patients can get involved.
0:26 | Overview on this cannabis and chronic pain study.
1:35 | Why chronic pain was the focus condition for this study.
2:22 | Why this study is important for patients world-wide
3:04 | Study duration and participation goals
3:35 | Current insights from the study.
4:20 | Requirements for individuals who want to be a part of the study.
4:56 | Taking part in the study: what to expect.
6:15 | Cost of participation in the trial for patients.
Participant eligibility requirements
– 18+ years of age;
– Eligible to be prescribed the NanoCelle® cannabis-based formulation for the management of cancer related or non-cancer-related pain;
– Must refrain from using other cannabis products;
– Willing to participate for 12 months;
– Complete a monthly feedback/observation session
Cost of Participation:
Participants in the study will receive their Medlab cannabis product at a subsidised rate (50% off) for the duration of their participation in the study. The cost of your doctor visits, however, will be at your own expense.
After the clinical trial, if you decide to continue to use the Medlab product to manage your symptoms, the product will be purchasable at the non-subsidised price.
To read the article, please visit:
To ask an expert a question visit:
The team at honahlee are not doctors and are not providing medical advice. Neither Courtney Fletcher nor the honahlee team are recommending the use of marijuana (cannabis) for medical or adult use purposes. Cannabis does not work for everyone and may have negative side effects. In Australia, medical marijuana (cannabis) is regulated by the TGA. If you think cannabis is right for you, please consult with your doctor or specialist.